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Cannabis is a drug derived from hemp plant, Cannabis sativa, used both as a recreational drug or as medicine. It is a widespread
illegal substance, generally smoked for its hallucinogenic properties. Little is known about the adverse eﬀects of postnatal cannabis
exposure throw breastfeeding because of a lack of studies in lactating women. The active substance of cannabis is the delta 9
TetraHydroCannabinol (THC). Some studies conclude that it could decrease motor development of the child at one year of age.
Therefore, cannabis use and abuse of other drugs like alcohol, tobacco, or cocaine must be contraindicated during breastfeeding.
Mothers who use cannabis must stop breastfeeding, or ask for medical assistance to stop cannabis use in order to provide her baby
with all the beneﬁts of human milk.
Copyright © 2009 Aur´ elia Garry et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Breastfeeding is the natural way to feed an infant. It provides
beneﬁts to mother and infant and should be the optimal
feeding choice for most infants. It contains appropriate
amounts of carbohydrates, proteins, fats, minerals, and
vitamins, and provides hormones and growth factor as
well as maternal antibodies that allow the baby appropriate
growth and anti-infection defence. Moreover, breastfeeding
helps bonding between mother and child, which is especially
important when the mother is a drug addict. In most cases,
when the mother uses drugs, the risks incurred by the infant
outweigh the beneﬁts of breastfeeding [1]. Therefore, drug
abuse poses a threat for the health of both mother and
child.
Nevertheless, cannabis can also be used in therapy.
Indeed,medicalcannabiscanbeprescribedforpostoperative
pain. So far, this medical use of cannabis is legal only
in some countries including Canada, Belgium, Australia,
the Netherlands, the United Kingdom, New Zealand, Spain
and some states of North America. This usage generally
requires a prescription. Clinical trials on the therapeutic
eﬀects of the cannabis are in progress. A California health
care collective has developed a variety of alternative methods
of administering medical cannabis orally and externally to
avoid smoking which is the most widely used method of
administering cannabis. They provide an account of the pro-
duction, distribution, and administration of nonsmokable
c a n n a b i sp r o d u c t s[ 2].
The aim of this article is to attempt to answer the
question: could cannabis be used during breastfeeding?
2. DeﬁnitionandEpidemiologyofCannabisUse
The species Cannabis sativa comes from the hemp plant
a n di su s e df o rv a r i o u sp u r p o s e ss u c ha sﬁ b e r ,a sad r u g ,
as medicine, for oil, as food, and so forth. Cannabis, also
called marijuana or haschich, exists in diﬀerent forms.
From a cannabis seedling, three products can be obtained.
Marijuana comes from leaves, stems, and ﬂower buds which
aredried.Itisgenerallysmok edmix edwithtobacco ,rolledas
acigarette.Haschichisresinobtainedfromﬂowerbudsofthe
plant presented in compressed plates. It is generally smoked2 Journal of Toxicology
with tobacco and is often cut with other substances more
or less toxic. Haschich and marijuana oils are obtained by
percolation from haschich puriﬁed with an organic solvent
or alcohol. Oils contain more cannabinoids than the other
forms (30% to 60% of delta 9 TetraHydroCannabinol or
THC). They are placed on cigarette paper or added to joints
in order to increase their hallucinogenic power.
To determine the current patterns of substance use
among youths entering adulthood, sex and age-speciﬁc rates
of substance use (tobacco, alcohol, cannabis, etc.) in a
large sample of French youths aged 12–26 years have been
studied.Tobacco,cannabis,andpolysubstanceuseweremost
frequent among 19–21 year-olds with 10.9% of women
who regularly use cannabis, and 4,6% of women who use
tobacco with alcohol and cannabis. The age of initiation
of tobacco and cannabis use decreased. These results show
high prevalence rates of tobacco, alcohol, and drug use in
adolescents and young adults in France [3]. There were
1.2 millions regular cannabis users in France in 2005, and
half of these were daily users. Regular use has increased
against occasional use. According to the drugs addictions
and drugs European observatory, France is the leading
European country in terms of cannabis use in both adults
and youths. Would French breastfeeding women be more
concerned about cannabis use during breastfeeding than
other European breastfeeding women? [4]. Cannabis is the
illicit drug most often used by women of childbearing age.
Studies conducted by North American and English teams
from 1980 to 2000 show an incidence of cannabis use
during pregnancy of 3% to 30% (more often 10% to 15%).
The prevalence of substance use among adolescent mothers
is signiﬁcant. To capitalize on the large decrease in use
during pregnancy, drug prevention programs for adolescent
mothers should target the ﬁrst 6 months postpartum [5]. In
Canada, Fried revealed that 3% of pregnant women regularly
use cannabis during pregnancy [6].
3.Pharmacology Dataand
SideEffects of Cannabis
Cannabis is a recreational drug usually smoked with tobacco
in cigarettes, either on an occasional or regular basis. It
contains many compounds (more than 450). The active
alkaloid is the delta 9 TetraHydroCannabinol (THC), and
its concentration is variable according to the preparations
(<0.2% to >20%). Its half-life is 1 to 2.3 days, and traces can
persist for up to 4 to 6 weeks. It is rapidly distributed to the
brain and adipose tissue. It is stored in fat tissues for long
periods (weeks to months) [7].
THC is an agonist of the cannabinoid receptors CB1
located in the nervous system, and CB2 in the brain and
some parts of the immune system, notably in the spleen.
The endocannabinoid system plays several key roles in
pre- and postnatal development. Indeed, during foetal life,
the cannabinoid CB1 receptor acts on brain development,
regulating neural progenitor diﬀerentiation into neurones
and glia (as CB2 receptor) and guiding axonal migration and
synaptogenesis. Postnatally, CB1 receptor blockade induces
oral motor weakness, which reveals a critical role for CB1
receptors in the initiation of milk suckling by neonates [8].
Other observations support the existence of an unknown
cannabinoid receptor, with partial control over milk inges-
tion in newborns [9]. Moreover, the endocannabinoid
system interacts with a number of better known molecules
involved in appetite and weight regulation, including leptin,
ghrelin, and the melanocortins, which leads to the regulation
of energy balance and food intake [10]. Cannabinoids are
also involved in the expression of key genes for neural
development [11].
The THC acts on the mesocorticolimbic system via CB1
receptors, which inhibit GABA release, and thus dopamin-
ergic neurons are subsequently not inhibited anymore. The
eﬀects of this mechanism are euphoria, modiﬁcation of
lucidity and perceptions, and depersonalization. In animals,
THC induces well-deﬁned behavioural eﬀects. Indeed, it
produces a characteristic combination of four symptoms:
hypothermia, analgesia, hypoactivity, and catalepsy [12].
Other experiments showed distinct eﬀects of cannabis on
mice litters, such as lower body weight, when the parents
were drugged postnatally during the period of lactation
only [13]. In striatum, CB1 receptors decrease dopamine
and glutamate release and increase GABA activity in the
synapse, which causes locomotor activity slowdown. CB2
receptors are responsible for anti-inﬂammatory eﬀects, and
other therapeutic eﬀects like analgesia, antiemetic eﬀects and
decrease of intraocular pressure.
Cannabis causes sedation, weakness, and poor feeding
patterns in adult [7]. Moreover cannabis abuse seems to be
a risk factor for depressive symptoms [14]. Indeed, frequent
cannabis use in teenage girls predicts later depression
and anxiety [15]. Cannabis use is also associated with an
increased risk of developing schizophrenia [16]. The relative
risk for schizophrenia among high consumers of cannabis
was 6.0 compared with nonusers [17].
4.CannabisandBreastfeeding
4.1. Pharmacokinetic Data. Cannabis sativa grows abun-
dantly among other natural vegetation in Pakistan, and it
has been reported that buﬀaloes which graze upon this
vegetation produce milk contaminated with THC. Low levels
of the major metabolite for THC were found in the urine
of children of the region, who were being raised on the
milk from these animals. These observations suggest passive
consumption of marijuana through milk [18].
THC is excreted into human breast milk in moderate
amounts [19]. In one feeding, the infant would ingest 0.8%
of the weight-adjusted maternal intake of one joint [20]. The
ratio milk-to-plasma rates 8 in heavy users [19].
Cannabis may aﬀect the quality and quantity of breast
milk [21]. Indeed, studies in animals suggest that marijuana
could inhibit lactation by inhibiting prolactin production
and, possibly, by a direct action on the mammary glands [7].
Hale reports a positive evidence of risk on milk production.
Nevertheless, there are no human data to corroborate these
observations.Journal of Toxicology 3
4.2. Side Eﬀects on Baby and Infant. There are a few studies
about the eﬀects of cannabis consumption during lactation
on infant health and development. More attention has
been directed towards adverse eﬀects of prenatal cannabis
exposure.
It is important to note that newborns have also probably
been exposed to cannabis during pregnancy. Therefore the
eﬀects observed in infant during breastfeeding will be the
combined result of foetal and neonatal exposure. Moreover,
cannabisisoftencombinedwithtobaccoinajoint.Thus,side
eﬀects of tobacco on infant must be considered.
THC can accumulate in human breast milk to high
concentrations [19], and infants exposed to marijuana
through their mother’s milk will excrete THC in their urine
during 2 to 3 weeks [21]. According to Hale, marijuana
could produce sedation and growth delay in infant [7], and
a study by Liston have demonstrated that infants exposed to
marijuana via breast milk show signs of sedation, reduced
muscular tonus, and poor sucking [21].
Moreover, because the important phase of brain growth
occurs during baby’s ﬁrst months of life, THC could
theoretically alter brain cells metabolism. Animal studies
have demonstrated alteration of DNA and RNA synthesis,
and proteins needed for proper growth and development
impaired in brain cells of newborn animals [21].
Two studies evaluated the eﬀects of cannabis use by
lactating mother on their child’s development. In the ﬁrst
study, no signiﬁcant diﬀerences were found in terms of
weaning, growth, and mental or motor development with
regard to age [22]. The second study found that cannabis
exposure via the mother’s milk during the ﬁrst month
postpartum appeared to be associated with a decrease in
infantmotordevelopmentatoneyearofage.Infantsexposed
to cannabis for more than half of the days during the
ﬁrst trimester of gestation or the ﬁrst month of lactation
had signiﬁcantly lower mean Psychomotor Development
Index scores than infants with no cannabis exposure (cf.
Table 1). The study did not ﬁnd a correlation between
cannabisexposureduringthethirdmonthafterbirthandthe
motordevelopment.Therewasnorelationbetweenexposure
cannabis during the ﬁrst and the third month after birth and
the mental development of the infant. However, it remains
a preliminary study, and the cause-eﬀect relation between
cannabis exposure during breastfeeding and decrease of the
motor development of the infant is not necessarily simple
and direct. Other factors come into play like cannabis
exposure during pregnancy, passive exposure to cannabis
smoke in ambient air, or the quality of the mother-child
relationship [23]. There are no studies relating to the long-
term eﬀects of marijuana exposure through breast milk.
Many of these ﬁndings remain suggestive due to the
number of factors associated with cannabis use which are
diﬃcult to control in epidemiologic and clinical studies.
Concerning side eﬀects of tobacco on infants, a study
investigated the eﬀects of smoke exposure via mothers’ milk
and/or via passive smoking during the ﬁrst year of life. At
birth, mean body weight of neonates from smoking mothers
was signiﬁcantly lower than the weight of neonates from
nonsmoking mothers. But this diﬀerence was no longer
Table 1: Mean motor development scores∗ corresponding with
cannabis exposure during gestation and lactation [23].
Motor Development PDI
Days of infant
Cannabis exposure
Mean
Trimester one
0 105 (n = 84)
1t o4 4 99 (n = 36)
45 to 90 93 (n = 16)
Trimester two
0 102 (n = 98)
1t o4 4 104 (n = 25)
45 to 90 94 (n = 13)
Trimester three
0 101 (n = 94)
1t o4 4 107 (n = 28)
45 to 90 94 (n = 14)
Lactation month one
0 102 (n = 81)
1t o4 4 106 (n = 38)
45 to 90 90 (n = 17)
Lactation month three
0 102 (n = 84)
1t o4 4 103 (n = 28)
45 to 90 97 (n = 13)
∗Motor developmental scores (Psychomotor Development Index, PDI)
were from Bayley Scales of Infant Development. During the ﬁrst trimester,
PDI decreased with increasing cannabis exposure (test for linear trend, P =
.005). During the ﬁrst lactation month, mean PDI for the higher exposure
group was lower than the PDI for the no or low exposure groups (one-way
ANOVA P = .008).
signiﬁcant in infants at 12 months of age. In this study,
neither psychomotor nor mental development was aﬀected
by smoke exposure during pregnancy and early infancy.
Infections of the lower respiratory tract were more frequent
in the children of smoking mothers. Breast-fed infants
showed concentrations of cotinine 10-fold higher than those
who were bottle fed. Nicotine exposure via passive smoking
only leads to cotinine excretion in urine of infants higher
than adult passive smokers [24].
4.3. Advice to Drug Addicted Mothers. Cannabis consump-
tion during breastfeeding is contraindicated according to
Hale and the American Academy of Pediatrics in Breastfeed-
ing Mothers. If the mother regularly uses cannabis, breast-
feeding is contraindicated. If the mother is an occasional
user and is not able to stop using cannabis, the situation
should be evaluated on a case-by-case basis (age of the
baby, quantities absorbed, etc.). Side eﬀects that cannabis
can cause must be explained to the mother. Pregnancy and
Addictions Studies Group recommends intensive prenatal
care, with substitution maintenance programs, by a medico-
psychosocial team working in concert with ambulatory4 Journal of Toxicology
health and social workers, to prevent perinatal complications
and mother-infant separation.
Moreover, the mother has to avoid cannabis smoke
exposure to her child and not to breastfeed during the
hours after cannabis use [21]. In all cases, the infant must
be carefully monitored, and both mother and baby should
follow a psychological and medical survey.
Mothers should be informed about the risk of sudden
infant death syndrome (SIDS) which is associated with
maternal smoking during and after pregnancy. The odds
ratio for SIDS among normal birth weight infants was
approximately 2 for passive exposure (only during infancy),
and raised to 3 for combined exposure (during pregnancy
and infancy). These data suggest that both intrauterine and
passive tobacco exposure are associated with an increased
risk of SIDS and are further inducement to encourage
smokingcessationamongpregnantwomenandfamilieswith
children [25]. However, another study has been performed
to determine whether maternal or paternal use of drugs
during conception, pregnancy, and postnatally increases the
risk of SIDS during the ﬁrst year of the infant’s life. Their
results show that there was no association between maternal
recreational drug use and SIDS. But paternal marijuana use
duringtheperiodsofconception,pregnancy,andpostnatally
was signiﬁcantly associated with SIDS [26].
5. Polyintoxications
From all of the above information, cannabis abuse during
breastfeeding is not allowed. Mothers who use cannabis may
also use other drugs like amphetamine, cocaine, heroine,
and so forth. According to the Committee on Drugs of
the American Academy of Pediatrics, these drugs belong
to drugs of abuse for which adverse eﬀects on the infant
during breastfeeding have been reported. For example,
cocaine intoxication can cause irritability, vomiting, diar-
rhoea, tremulousness, and seizures [27]. Therefore, other
drug consumption must be taken into account.
6. Conclusion
In conclusion, clinical and pharmacokinetic data indicate
that cannabis use is dangerous during breastfeeding for
the child. Observed eﬀects in breastfed infant like sedation
or reduced muscular tonus could be due to, not only
cannabis, but also other drugs or medicines (psychotropic,
antiepileptic, etc.) that mothers are likely to take.
Mothers who are drug addicts and want to breastfeed
their infant must be sustained by a multidisciplinary team.
A substitution treatment like methadone should be chosen
i no r d e rt os t o pd r u gu s ea n dt op r o t e c tt h e i rc h i l d
from drug side eﬀects. Medical teams must be advised
about medication, alcohol, and other drugs abuse that
could be contraindicated with breastfeeding. The Medic-
Al network provide health professionals and patients with
up-to-date information [28]. Our references about drugs
and breastfeeding are (Addictions and Pregnancy Stud-
ies Group (GEGA), Regional Pharmacovigilance Centre
(CRPV), Reference Centre on Teratogenic Agents (CRAT),
and Mother Risk Program, etc.). Medic-Al network will
facilitate discussion about pharmacokinetic data in maternal
milk and allow comparative study about potential beneﬁts
and risks.
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